CompletedPhase 2ketamine

Use of Ketamine Prior to Cardiopulmonary Bypass in Children

Sponsored by Arkansas Children's Hospital Research Institute

NCT ID
NCT00556361
Target Enrollment
24 participants
Start Date
2004-07
Est. Completion
2007-11

About This Study

To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.

Conditions Studied

Ventricular Septal Defect

Interventions

  • saline
  • ketamine

Eligibility

Age:N/A - 1 Year
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* less than one year of age
* undergoing cardiac surgery for repair of ventricular septal defect
* requiring cardiopulmonary bypass
* not requiring retrogrades cerebral perfusion

Exclusion Criteria:

* Downs Syndrome

Study Locations (1)

Arkansas Children's Hospital
Little Rock, Arkansas, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source